Question

A client admitted with an acute coronary syndrome (ACS) receives eptifibatide, a glycoprotein (GP) IIB IIIA inhibitor, which important finding places the client at greatest risk?

Answer 1

Receiving eptifibatide, a glycoprotein (GP) IIB IIIA inhibitor, places a client with acute coronary syndrome (ACS) at greatest risk if they have underlying atherosclerosis.

Step-by-step explanation:

Receiving eptifibatide, a glycoprotein (GP) IIB IIIA inhibitor, places a client with acute coronary syndrome (ACS) at greatest risk if they have an underlying atherosclerosis. Atherosclerosis is a condition characterized by the buildup of plaque in the arteries. People with this disorder have a higher risk of myocardial infarction or stroke. Therefore, the client's risk is increased due to the combined effects of ACS and atherosclerosis.